An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

(2020) Hongzhou Lu et al.   JOURNAL OF MEDICAL VIROLOGY

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

(2020) Jasper Fuk-Woo Chan et al.   Emerging Microbes & Infections

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain

(2019) Yusen Zhou et al.   Viruses-Basel

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

(2019) Shuai Xia et al.   Science Advances

The prevalence of VAIN, CIN, and related HPV genotypes in Japanese women with abnormal cytology

(2019) Shitai Zhang et al.   JOURNAL OF MEDICAL VIROLOGY

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses

(2017) Lei-Ping Zeng et al.   Science China-Life Sciences

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein

(2017) Yingzhu Chen et al.   Emerging Microbes & Infections

MERS-CoV spike protein: a key target for antivirals

(2016) Lanying Du et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines

(2016) Lanying Du et al.   Nature Communications

Evaluation of candidate vaccine approaches for MERS-CoV

(2015) Lingshu Wang et al.   Nature Communications

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

(2009) Lanying Du et al.   NATURE REVIEWS MICROBIOLOGY